Fingerprint
Dive into the research topics of 'Randomized phase II study of ramucirumab or icrucumab in combination with capecitabine in patients with previously treated locally advanced or metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically